Skip to main content
HHS
.gov
Health Information Privacy
Search
U.S. Department of Health & Human Services
Search
Close
A-Z Index
HIPAA for Individuals
Filing a Complaint
HIPAA for Professionals
Newsroom
Breadcrumb
HHS
>
HIPAA Home
>
For Professionals
>
FAQ
> Transition Provisions
Text Resize
A
A
A
Print
Share
Authorizations (30)
Business Associates (41)
Compliance Dates (2)
Covered Entities (14)
Decedents (9)
Disclosures for Law Enforcement Purposes (5)
Disclosures for Rule Enforcement (1)
Disclosures in Emergency Situations (2)
Disclosures Required by Law (6)
Disclosures to Family and Friends (28)
Disposal of Protected Health Information (6)
Facility Directories (7)
Family Medical History Information (3)
FERPA and HIPAA (10)
Group Health Plans (3)
Health Information Technology (41)
Incidental Uses and Disclosures (10)
Judicial and Administrative Proceedings (8)
Limited Data Set (6)
Marketing (18)
Marketing - Refill Reminders (16)
Mental Health (35)
Minimum Necessary (14)
Notice of Privacy Practice (20)
Personal Representatives and Minors (12)
Preemption of State Law (10)
Privacy Rule: General Topics (12)
Protected Health Information (2)
Public Health Uses and Disclosures (13)
Research Uses and Disclosures (20)
Right to Access and Research (58)
Right to an Accounting of Disclosures (8)
Right to File a Complaint (1)
Right to Request a Restriction (3)
Safeguards (13)
Security Rule (24)
Smaller Providers and Businesses (145)
Student Immunizations (8)
Telehealth (11)
Transition Provisions (3)
Treatment, Payment, and Health Care Operations Disclosures (30)
Workers Compensation Disclosures (5)
Transition Provisions
Can researchers continue to access existing databanks or repositories that are maintained by covered entities, even if those databases were created prior to the compliance date without patient permission or without a waiver of informed consent by an Institutional Review Board (IRB)?
If research subjects' consent was obtained before the compliance date, but the Institutional Review Board (IRB) subsequently modifies the informed consent document after the compliance date and requires that subjects be reconsented, is authorization now required from these previously enrolled research subjects under the HIPAA Privacy Rule?
Were there Privacy Rule compliance deadlines in 2004?
Back to
T
op
